"Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease". Parkinsonism Relat. Disord. 14 (4): 273-80. 2008. doi:10.1016/j.parkreldis.2007.09.007. PMID17988927.
"Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?". Lancet Neurol. 2 (10): 595-604. October 2003. doi:10.1016/S1474-4422(03)00529-5. PMID14505581.
"Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease". Mov. Disord. 20 (1): 77-81. January 2005. doi:10.1002/mds.20288. PMID15390130.
"Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease". Journal of Neurology. 260 (2): 521-517. February 2013. doi:10.1007/s00415-012-6669-1. PMID23007193.
"Successful treatment of dopamine dysregulation syndrome with valproic acid". The Journal of Neuropsychiatry and Clinical Neurosciences. 26 (3): E3. 2014. doi:10.1176/appi.neuropsych.13060126. PMID25093777.
"Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease". Parkinsonism Relat. Disord. 14 (4): 273-80. 2008. doi:10.1016/j.parkreldis.2007.09.007. PMID17988927.
"Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?". Lancet Neurol. 2 (10): 595-604. October 2003. doi:10.1016/S1474-4422(03)00529-5. PMID14505581.
"Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease". Mov. Disord. 20 (1): 77-81. January 2005. doi:10.1002/mds.20288. PMID15390130.
"Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease". Journal of Neurology. 260 (2): 521-517. February 2013. doi:10.1007/s00415-012-6669-1. PMID23007193.
"Successful treatment of dopamine dysregulation syndrome with valproic acid". The Journal of Neuropsychiatry and Clinical Neurosciences. 26 (3): E3. 2014. doi:10.1176/appi.neuropsych.13060126. PMID25093777.